Joseph Flanagan

Joseph Flanagan is an Analyst at Moore Capital Management in New York, having joined the firm in March 2025. In his current role, he conducts in-depth investment analysis and supports portfolio management decisions across multiple asset classes, with a primary focus on public equities. His coverage is particularly strong in the healthcare and biotechnology sectors, reflecting experience in tracking industry fundamentals, earnings, and market-moving events.

Previously, Joseph held the position of Vice President and Associate in Equity Research at Cowen Inc., where he specialized in healthcare and biopharma sectors from mid-2021 to early 2025. His responsibilities included financial modeling, sector due diligence, and authoring investment research reports used by institutional clients to guide investment decisions. His direct involvement in earnings calls and industry events further honed his expertise in the dynamics and valuation of bio-pharma and life sciences companies.

Joseph holds a Bachelor’s degree in Finance and Accounting from Ithaca College and is recognized for his robust analytical skills and sector-specific knowledge. His expertise in healthcare and biopharma investment research is underscored by a track record of insightful market coverage and sector leadership within investment banking and hedge fund environments.